 |
|
 |
Latin America |
|
|
Generic Option; The
Publication Date July 2006
Publisher Business Monitor
Product Type Report
Pages 94
ISBN Number not applicable
Product Code BMI078
|
|
|
Summary
It is believed that there is substantial unmet demand for advanced generics in Latin America, and that the region is set to emerge as a globally significant market for off-patent medicines. However, growth will be uneven, with poorly regulated markets seeing little or no development away from locally-made, inferior copies. The value of the legitimate generics markets of the leading nine Latin America economies is conservatively expected to reach US$6.4bn at consumer prices by year-end 2009.
The Generic Option - Impacts for Latin America's Pharmaceuticals Markets, covering Argentina, Brazil, Chile, Colombia, Mexico, Peru, Uruguay, Venezuela and the signatory states of the CAFTA-DR trade accords with the USA.
Companies covered in the Report include: Laboratorios Roemmers, Laboratorios Bag, EMS Sigma, Eurofarma, Laboratrios Ache, Biosinttica, Medley, LabChile, Laboratorios Andrmaco, Tecnoqumicas, Lafrancol, Laboratorios Elmor, Novartis and Merck KGaA
Key Benefits of the Report
Comparative analyses and 4-year forecasts to end-year 2009 for all key generic drugs markets in Latin America, analysing value and market share of legitimate generics sector at final retail prices. The Report covers Argentina, Brazil, Chile, Colombia, Mexico, Peru, Uruguay, Venezuela and the signatory states of the CAFTA-DR trade accords with the USA. The Report also evaluates key aspects of the business environment in other regional markets including Ecuador, Bolivia and Paraguay.
BMI's macroeconomic assumptions over the 4-year forecast horizon, which underpin our 4-year industry forecasts. Macroeconomic forecasts derive from BMI's econometric model of the world.
Evaluation of recent trends driving industry performance and 4-year outlook in each market, focusing on principal epidemiological and demographic trends, fastest-growing product segments and investment hot spots, the impact of healthcare reforms, the direction of sector regulation, drug pricing and reimbursement, and the strategic objectives of national pharmaceuticals industry policies.
Analysis of the impact of global consolidation and expansion of the generic pharmaceuticals industry, including an appraisal of the local activities of leading foreign players, their products, investments and regional expansion strategies.
Business environment rankings for the leading generic markets. Each Country Landscape provides a 4-year forecast to year-end 2009 for the value and market share of the legitimate generics sector at final retail prices.
Competitive intelligence, company profiles and SWOT analyses for the leading indigenous and multinational generic pharmaceuticals producers, including Laboratorios Roemmers, Laboratorios Bago, EMS Sigma, Eurofarma, Laboratorios Ache, Biosintetica, Medley, LabChile, Laboratorios Andromaco, Tecnoquimicas, Lafrancol, Laboratorios Elmor, Novartis, Merck KGaA
|
Content
Aim Of The Report
Executive Summary
Regulatory Developments
Industry Developments
Forecast
Introduction: The Latin American
Pharmaceuticals Market
Chapter 1: Industry Trends & Developments
Healthcare Reform and Medicines Access
Mexico and Brazil: Towards Universal Provision
Healthcare and Generics in Argentina and Chile
Chapter 2: Regulatory Development In Latin America
Intellectual Property Reform
Table - Free trade agreements in Latin America
Table - Intellectual property and drug registration
Copy Drugs: The Problem of Definition
Bioequivalence and GMP
Table - Bioequivalence and GMP
Table - Mexican equivalence requirements for generics
Table - Summary: Core Generic Medicines Legislation in
Latin America
Chapter 3: Pharmaceutical Pricing Policy
Table - Drug price controls in Latin America
Chapter 4: Generics & Industrial Strategy
Technology Transfer and Public Health
Brazil - ARVs used in DST-AIDS programme, 2005
Table - Assets of Indian generic drug firms in Latin America
Latin America and Global Generics Sector Consolidation
Table - FDI in Latin American Generics Sector
Prospects for the Generic Drug Export Sector
Patent Expiries and the Generics Sector
Table - Major US pharmaceutical patent expiries, 2005-2007
Chapter 5: Country Landscapes
Map - Latin American generics market, 2005
Argentina
Market Developments
Competitive Environment
Table - Market share of leading drug distributors
Market Forecast
Argentina - Generics market forecast data
Brazil
Market Developments
Competitive Environment
Table - Leading 20 generics in Brazil, 2004
Market Forecast
Brazil - Generics market forecast data
Chile
Market Developments
Competitive Environment
Market Forecast
Chile - Generics market forecast data
Colombia
Market Developments
Competitive Environment
Market Forecast
Colombia - Generics market forecast data
Mexico
Market Developments
Competitive Environment
Market Forecast
Mexico - Generics market forecast data
Peru
Market Developments
Competitive Environment
Market Forecast
Peru - Generics market forecast data
Puerto Rico
Market Developments
Competitive Environment
Forecast
Puerto Rico - Generics market forecast data
Uruguay
Market Developments
Competitive Environment
Forecast
Uruguay - Generics market forecast data
Venezuela
Market Developments
Competitive Environment
Market Forecast
Venezuela - Generics market forecast data
CAFTA-DR markets
Market Developments
Competitive Environment
Conclusion
SWOT
Business Environment Ranking
Table - Latin America Generic Pharmaceuticals Business
Environment Ranking
Chapter 6: Company Profiles - Indigenous Manufacturers
Laboratorios Roemmers
Strengths
Weaknesses
Opportunities
Threats
Overview
Product portfolio
Regional Activities/Outlook
Laboratorios Bag
Strengths
Weaknesses
Opportunities
Threats
Overview
Regional Presence
Product Portfolio
Alliances & Partnerships
THE GENERIC OPTION:
Recent Activities
EMS Sigma
Strengths
Weaknesses
Opportunities
Threats
Overview
Product Portfolio
Recent Activity
Eurofarma
Strengths
Weaknesses
Opportunities
Threats
Overview
Product Portfolio
Laboratrios Ach
Strengths
Weaknesses
Opportunities
Threats
Overview
Product Portfolio
Biosinttica
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Overview
Alliances/Partnerships
Medley
Strengths
Weaknesses
Opportunities
Threats
Overview
Alliances/Partnerships
Product Portfolio
LabChile
Strengths
Weaknesses
Opportunities
Threats
Overview
Regional Presence
Laboratorios Andrmaco
Strengths
Weaknesses
Opportunities
Threats
Overview
Alliances & Acquisitions
Product Portfolio
Tecnoqumicas
Strengths
Weaknesses
Opportunities
Threats
Overview
Product Portfolio
Lafrancol
Strengths
Weaknesses
Opportunities
Threats
Overview
Product Portfolio
Laboratorios Elmor
Strengths
Weaknesses
Opportunities
Threats
Overview
Company Profiles - Multinational Generics Manufacturers
Novartis
Strengths
Weaknesses
Opportunities
Threats
Overview
Regional Activities - Brazil
Regional Activities - Mexico
Product Portfolio
Merck KGaA
Strengths
Weaknesses
Opportunities
Threats
Overview
Regional Activities - Mexico
Regional Activities - Brazil
Appendix 1: Economic Trends & Outlook
Argentina
Table - Economic Activity - Historical Data And Forecasts
Brazil
Table - Economic Activity - Historical Data And Forecasts
Chile
Table - Economic Activity - Historical Data And Forecasts
Colombia
Table - Economic Activity - Historical Data And Forecasts
Mexico
Table - Economic Activity - Historical Data And Forecasts
Peru
Table: Economic Activity-Historical Data And Forecasts
Venezuela
Table: Economic Activity - Historical Data And Forecasts
Appendix 2: Sources - Latin American
Pharmaceuticals Industry
|
|
|
